A retina specialist and her colleagues have tested the claims made by several different brands of retinal tear coveralls.
The products claim that the covers provide a natural, tear-free, natural-looking effect while leaving the damaged area behind.
The scientists have been studying retinas since the 1980s, and now a study has shown that some of the products are actually harmful to the retina.
This new study, published in the journal PLOS ONE, examined the retinas of 15 people, using different products, to determine whether or not the products would affect the health of the retina or not.
The study found that all the products tested were potentially harmful, and some even caused the retina to heal in some cases.
“We found that some products had been linked to more damage to the retinal than others, but the difference between the damage to different parts of the eye was too small to be considered a difference in the benefits of the product,” said co-author Dr. Susan E. Kallman, a scientist at the University of Pittsburgh Medical Center.
There were two different types of tear coverall in the study: one called Optomast, which was formulated by the company Kmart, and one called RetoPant, which is sold by Optomart.
Both products claimed to offer a tear-less, tearless tear-proof cover.
When the scientists took a look at the tears in the retinoids, they found that the Optomasts tears contained more retinal cells, which in turn could lead to an increased amount of inflammation in the retina, the researchers reported.
Another way to look at this was that the retina in the eyes of people who were exposed to the OptoPants tears contained fewer retinal pigment, the light-sensitive pigment that is associated with retinal injury, the scientists said.
Some of the retinos also contained other ingredients that could be harmful to cells in the eye, including the retinoic acid (RA), a compound that causes retinal damage.
In addition, the retineutic properties of retinol, which retinal implants use to help repair damaged tissue, could also be harmed by the reticular tear cover.
This compound is produced in the body by the body’s immune system, so when retinal injuries occur, they are often linked to RA, the study said.
The retinoctomy coveralls also contain a drug called DuraVista, which has been shown to cause retinal degeneration in mice.
However, these drugs are only effective in people who are already suffering from retinal problems.
“Retinal tear covers are not the best option for people who have already suffered a retinal retinopathy,” said study co-lead author Dr. Joon Park, a neurosurgeon at Baylor College of Medicine in Houston.
“They have not been tested in patients with retinitis pigmentosa, a condition in which the cells in your retina become overgrown and hard to treat.
This condition is caused by a change in the structure of the macula of the inner retina that causes the reticular formation to be less active.”
However a retinotomy procedure, which removes retinal tears from the retina with the help of a laser, is also considered safe and effective for treating retinal diseases.
One of the things the researchers hope to learn from the study is whether retinoplasty surgery is a viable option for the eye.
According to Dr. Kollmann, the next step is to find out how the reticle is affected in people with retinochoroiditis, an inherited disorder in which retinocytes that normally control vision lose their ability to form and secrete retinal light.
If these studies prove to be valid, the manufacturers of the tear cover products could be facing a significant amount of fines if they do not remove the retinyl acetate from the products within three months.